Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | STAT3 | P40763 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30244568 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL16898428 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL15416739 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL483840 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL1742594 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL23417950 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL7519771 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL11516145 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL16899885 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL564403 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118930795-A | High-hydrophilicity polyurethane filter cotton and preparation method thereof | 江苏裕辉宏新材料科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118480075-B | Method for preparing red photoetching hydrogel by utilizing photoresponsive ruthenium complex cross-linking agent and application of red photoetching hydrogel in cell culture | 中国科学技术大学 | 2024-09-17 | — | — | CN | claimed |
| CN-118515678-A | Amphiphilic zinc porphyrin fluorescent dye, photo-thermal nanoparticle, and methods and applications thereof | 安徽师范大学 | 2024-08-20 | — | — | CN | claimed |
| CN-118480075-A | Method for preparing red photoetching hydrogel by utilizing photoresponsive ruthenium complex cross-linking agent and application of red photoetching hydrogel in cell culture | 中国科学技术大学 | 2024-08-13 | — | — | CN | claimed |
| CN-117567707-B | Phenolic resin for building materials and preparation method thereof | 山东宇世巨化工有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117567707-A | Phenolic resin for building materials and preparation method thereof | 山东宇世巨化工有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-116426457-B | Extraction process of aloe arborescens protoplast | 山东鲁台农业科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116426457-A | Extraction process of aloe arborescens protoplast | 山东爱维德生物科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-111233822-B | Crown ether modified ligand, four-metal Pt rectangular supramolecular complex, and preparation method and application thereof | 山东师范大学 | 2021-01-08 | — | — | CN | claimed |
| CN-111233822-A | Crown ether modified ligand, four-metal Pt rectangular supramolecular complex, and preparation method and application thereof | 山东师范大学 | 2020-06-05 | — | — | CN | claimed |
| CN-102250102-A | Alpha(beta)quinoline-oligopolycthylene glycol phthalocyanine zinc and preparation method thereof | UNIV FUZHOU | 2011-11-23 | — | — | CN | claimed |
| CN-102250101-A | Bis-alpha-quinoline-low molecular polyethylene glycol phthalocyanine zinc and preparation method thereof | UNIV FUZHOU | 2011-11-23 | — | — | CN | claimed |
| US-20260125410-A1 | MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS | UNIV YALE (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260115300-A1 | GLYCOTARGETING THERAPEUTICS | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2026-04-30 | — | — | US | disclosed |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | UNIV YALE (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | UNIV JOHNS HOPKINS (US) | 2026-04-16 | — | — | US | disclosed |
| US-20050142061-A1 | Radiofluorination methods | GE HEALTHCARE LIMITED (GB) | 2005-06-30 | — | — | US | disclosed |
| EP-1487762-A1 | RADIOFLUORINATION METHODS | Amersham plc (GB) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003080544-A1 | RADIOFLUORINATION METHODS | AMERSHAM PLC (GB) | 2003-10-02 | — | — | WO | disclosed |
| US-4145342-A | NITRO-DIPHENYLAMINO-AZO-PHENYL DYESTUFFS CONTAINING A POLYALKYENEOXY GROUP | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | CNR1, CNR2, GPR18 | ALDH1A1 3449/4885CA1 3055/4885CA12 2944/4885 |
| US-20050142061-A1 | Radiofluorination methods | SSTR4, VIP, SSTR5 | ALDH1A1 3939/4885CA1 426/4885CA12 649/4885 |
| US-20260125410-A1 | MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS | ASGR1, COL2A1, FCGR2A | ALDH1A1 3257/4885CA1 3276/4885CA12 2744/4885 |
| US-20260115300-A1 | GLYCOTARGETING THERAPEUTICS | CD74, HLA-DRB1, CD69 | ALDH1A1 555/4885CA1 1748/4885CA12 1382/4885 |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | CRBN, VHL, ADRM1 | ALDH1A1 2777/4885CA1 3147/4885CA12 3515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.